Compounds > ranolazine
Page last updated: 2024-08-24

ranolazine and Insulin Sensitivity

ranolazine has been researched along with Insulin Sensitivity in 7 studies

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (28.57)29.6817
2010's2 (28.57)24.3611
2020's3 (42.86)2.80

Authors

AuthorsStudies
Braczko, A; Chlopicki, S; Jablonska, P; Jedrzejewska, A; Krol, O; Kus, F; Mika, A; Przyborowski, K; Sledzinski, T; Slominska, EM; Smolenski, RT; Tomczyk, M1
Eaton, F; Gopal, K; Greenwell, AA; Saed, CT; Tabatabaei Dakhili, SA; Ussher, JR1
Aldasoro, C; Aldasoro, M; Arias-Mutis, OJ; Guerra-Ojeda, S; Jorda, A; Valles, SL; Vila, JM1
Battaglia, D; Caminiti, G; Fossati, C; Massaro, R; Rosano, G; Volterrani, M1
Benedini, S; Luzi, L; Montesano, A; Senesi, P; Terruzzi, I; Vacante, F1
Taegtmeyer, H1
Marazzi, G; Rosano, GM; Volterrani, M1

Other Studies

7 other study(ies) available for ranolazine and Insulin Sensitivity

ArticleYear
Enhanced Muscle Strength in Dyslipidemic Mice and Its Relation to Increased Capacity for Fatty Acid Oxidation.
    International journal of molecular sciences, 2021, Nov-12, Volume: 22, Issue:22

    Topics: Adenine Nucleotides; Animals; Apolipoproteins E; Blood Glucose; Dyslipidemias; Fatty Acids; Insulin Resistance; Lipids; Mice, Inbred C57BL; Mice, Knockout; Mitochondria, Muscle; Muscle Strength; Muscle, Skeletal; Myosin Heavy Chains; Oxidation-Reduction; Ranolazine; Receptors, LDL; Troponin

2021
The anti-anginal ranolazine does not confer beneficial actions against hepatic steatosis in male mice subjected to high-fat diet and streptozotocin-induced type 2 diabetes.
    Canadian journal of physiology and pharmacology, 2022, Volume: 100, Issue:5

    Topics: Animals; Blood Glucose; Diabetes Mellitus, Type 2; Diet, High-Fat; Insulin Resistance; Liver; Male; Mice; Mice, Inbred C57BL; Non-alcoholic Fatty Liver Disease; Obesity; Ranolazine; Streptozocin; Triglycerides

2022
Improvement of Vascular Insulin Sensitivity by Ranolazine.
    International journal of molecular sciences, 2023, Aug-31, Volume: 24, Issue:17

    Topics: Adrenergic Agents; Animals; Aorta, Abdominal; Diabetes Mellitus, Type 2; Insulin Resistance; Rabbits; Ranolazine; Vasodilator Agents

2023
Ranolazine improves insulin resistance in non-diabetic patients with coronary heart disease. A pilot study.
    International journal of cardiology, 2016, Sep-15, Volume: 219

    Topics: Adult; Aged; Aged, 80 and over; Cardiovascular Agents; Coronary Disease; Diabetes Mellitus, Type 2; Exercise Test; Female; Follow-Up Studies; Humans; Insulin Resistance; Male; Middle Aged; Obesity; Pilot Projects; Ranolazine

2016
Ranolazine promotes muscle differentiation and reduces oxidative stress in C2C12 skeletal muscle cells.
    Endocrine, 2017, Volume: 58, Issue:1

    Topics: Animals; Apoptosis; Cell Differentiation; Cell Line; Cell Proliferation; Cell Survival; Enzyme Inhibitors; Insulin Resistance; Mice; Muscle Development; Muscle Fibers, Skeletal; Oxidative Stress; Ranolazine

2017
Cardiac metabolism as a target for the treatment of heart failure.
    Circulation, 2004, Aug-24, Volume: 110, Issue:8

    Topics: Acetanilides; Animals; Dogs; Energy Metabolism; Epoxy Compounds; Fatty Acids; Forecasting; Glucagon; Glucagon-Like Peptide 1; Glucose; Heart Failure; Humans; Insulin Resistance; Myocardium; Peptide Fragments; Piperazines; Protein Precursors; Ranolazine; Recombinant Proteins

2004
Metabolic agents in the management of diabetic coronary patients: a new era.
    International journal of cardiology, 2008, Jun-23, Volume: 127, Issue:1

    Topics: Acetanilides; Citric Acid Cycle; Coronary Disease; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Dichloroacetic Acid; Enzyme Inhibitors; Epoxy Compounds; Humans; Insulin Resistance; Perhexiline; Piperazines; Ranolazine; Trimetazidine; Vasodilator Agents

2008